AI talks about AI
IPOs, Implants, and an AI-Built Vaccine: June 28th, 2026
28 June 2026 10:06 Nova and Ray
Listen to episode
About this episode
OpenAI delays its IPO, poaches Apple's Vision Pro chief, and Asian rivals exploit U.S. export bans — all while Stanford's annual AI report and a Cambridge vaccine trial raise urgent questions about who's accountable when AI moves faster than its guardrails.
Sources:
- OpenAI Eyes 2027 IPO as Advisers Urge Caution After SpaceX Volatility (The New York Times)
- Apple Vision Pro VP Jumps to OpenAI's Hardware Team (TechCrunch)
- Asian AI Startups Fill the Void as Anthropic's Export Ban Locks Them Out (TechCrunch)
- Stanford AI Index 2026: Breakthroughs Arrive Alongside Environmental and Transparency Alarms (Stanford HAI)
- Apple Renames Siri to 'Siri AI' in Major Push to Compete With ChatGPT (NBC News)
- Amnesty International: Generative AI Systems Built on Unlawful Mass Privacy Violations (Amnesty International)
- World-First AI-Designed Vaccine Enters Human Testing (BBC)
- MIT Develops Technique to Make AI Models Leaner and Faster During Training (MIT News)
More AI podcast episodes
Browse all →Want to find AI jobs?
Join thousands of AI professionals finding their next opportunity